文献速递结核与非结核分枝杆菌

药理学抑制巨噬细胞甘油三酯生物合成通路不能改善感染小鼠的结核分枝杆菌控制

Pharmacologic Inhibition of Macrophage Triglyceride Biosynthesis Pathways Does Not Improve Mycobacterium tuberculosis Control in Infected Mice.
PubMed 文献 · J Infect Dis · 2025-01-01

研究评估DGAT1抑制剂A-922500(DGATi)和p70S6K抑制剂LY2584702(p70S6Ki)在感染结核分枝杆菌的人单核细胞来源巨噬细胞及C3HeB/FeJ小鼠肺内降低甘油三酯含量和菌负荷的能力。两种抑制剂均显著降低感染巨噬细胞的脂质含量和杆菌负荷,p70S6Ki单药治疗6周降低小鼠肺菌负荷,但DGATi单药及与异烟肼联用未降低肺菌负荷或改变肺部炎症。

要点

  • DGATi和p70S6Ki均显著降低感染巨噬细胞的脂质含量和杆菌负荷。
  • p70S6Ki单药治疗6周降低感染小鼠肺细菌负荷。
  • DGATi单药或与异烟肼联用未降低肺菌负荷或改变肺部炎症。

核心结论

  • 药理学抑制巨噬细胞甘油三酯生物合成通路在体外感染巨噬细胞中降低脂质和菌负荷,但仅p70S6Ki单药在感染小鼠中降低肺菌负荷,DGATi单药及与异烟肼联用无效。

研究设计与样本

  • 研究评估2种化合物在感染结核分枝杆菌的人单核细胞来源巨噬细胞和感染结核分枝杆菌的C3HeB/FeJ小鼠肺内的效果:A-922500(DGATi)为二酰甘油O-酰基转移酶1抑制剂,LY2584702(p70S6Ki)为p70 S6激酶抑制剂。

主要发现

  • DGATi和p70S6Ki显著降低感染结核分枝杆菌巨噬细胞的脂质含量和杆菌负荷。
  • 每种抑制剂均降低感染小鼠支气管肺泡灌洗样本的细胞甘油三酯含量。
  • 治疗6周后,p70S6Ki单药降低感染小鼠肺细菌负荷。
  • DGATi单药以及DGATi或p70S6Ki与异烟肼联用未降低肺细菌负荷或改变肺部炎症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Tuberculosis necrotic granulomas contain triglyceride-rich macrophages (foam cells) with reduced antimicrobial functions. We assessed the ability of 2 compounds to reduce the triglyceride content and Mycobacterium tuberculosis (Mtb) burden in infected human monocyte-derived macrophages and in the lungs of Mtb-infected C3HeB/FeJ mice: A-922500 (DGATi), an inhibitor of diacylglycerol O-acyltransferase 1, and LY2584702 (p70S6Ki), an inhibitor of p70 S6 kinase. DGATi and p70S6Ki significantly reduced the lipid content and bacillary burden in Mtb-infected macrophages. Each inhibitor reduced the cellular triglyceride content in bronchoalveolar lavage samples of Mtb-infected mice. After 6 weeks of treatment, p70S6Ki alone reduced the lung bacterial burden in Mtb-infected mice. However, DGATi alone and DGATi or p70S6Ki in combination with isoniazid did not reduce lung bacterial burden or alter lung inflammation. These findings provide further insight into the role of foam cells in tuberculosis pathogenesis and the utility of interventions targeting these cell populations as adjunctive host-directed therapies.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Ruelas Castillo J, Guerrini V, Quijada D, et al. Pharmacologic Inhibition of Macrophage Triglyceride Biosynthesis Pathways Does Not Improve Mycobacterium tuberculosis Control in Infected Mice. J Infect Dis. 2025. PMID: 39560474. doi:10.1093/infdis/jiae577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。